# FDA Inspection 1106464 - Wake Forest University School of Medicine - September 30, 2019

Source: https://www.keypedia.com/records/fda_inspections/wake-forest-university-school-of-medicine/7bd113c2-c427-4305-849a-74a4ad888d7c
Source feed: FDA_Inspections

> FDA Inspection 1106464 for Wake Forest University School of Medicine on September 30, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106464
- Company Name: Wake Forest University School of Medicine
- Inspection Date: 2019-09-30
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 869614 - 2014-03-12](https://www.keypedia.com/records/fda_inspections/wake-forest-university-school-of-medicine/bffbe8a3-05f5-4719-99a6-1efff9bd5810)

Company: https://www.keypedia.com/companies/wake-forest-university-school-of-medicine/fa6c3f40-6b58-4d12-a525-63c7b4832cf2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d